Cerebrospinal fluid P-tau181P: biomarker for improved differential dementia diagnosis

The goal of this study is to investigate the value of tau phosphorylated at threonine 181 (P-tau181P) in the Alzheimer’s disease (AD) cerebrospinal fluid (CSF) biomarker panel for differential dementia diagnosis in autopsy confirmed AD and non-AD patients.The study population consisted of 140 autops...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Hanne eStruyfs, Ellis eNiemantsverdriet, Joery eGoossens, Erik eFransen, Jean-Jacques eMartin, Peter Paul De Deyn, Sebastiaan eEngelborghs
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2015-06-01
Serija:	Frontiers in Neurology
Teme:	Cerebrospinal Fluid Dementia biomarkers Alzheimer’s disease tau Neuropathology
Online dostop:	http://journal.frontiersin.org/Journal/10.3389/fneur.2015.00138/full
Oznake:	Označite Brez oznak, prvi označite!